Company
United StatesPublic company, NYSE: MDTMedtronic Inc (NYSE: MDT), Portland, OR – FDA Inspections
Inspection records and compliance data for Medtronic Inc in Portland, Oregon. 2 FDA inspections on record, last inspected September 22, 2014. Publicly traded as NYSE: MDT.
Company Profile
This profile covers Medtronic Inc based in Portland, Oregon, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected January 9, 2012. Last inspected September 22, 2014.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 22, 2014 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 896598 |
| January 9, 2012 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 762177 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Medtronic Inc
Stock ticker
MDT
Exchange
NYSE
Share price
$105.03
Market cap
$134.3B
Price as of
November 6, 2026
FEI Number
3004107675
Address
4380 SW Macadam Ave Ste 121, Portland, Oregon 97239, United States
Country
United States
ID: 66442677-628f-4827-963f-19444735e580